S. Korean bio firms in race for COVID-19 treatment, vaccine development
Oct 3, 2020
South Korean pharmaceutical companies have joined the global race to develop vaccines and treatments for the novel coronavirus, and several of them have received approval for clinical trials from the country's drug safety agency. Among the front-runners is Celltrion Inc.'s antiviral antibody treatment candidate called CT-P59 that is currently undergoing phase two and three trials both at home and abroad. Celltrion said it has completed phase one clinical trials on 32 healthy adults in the coun